Most People Stop Ozempic after Two Years. What Happens to Weight and Health?
Ozempic and similar GLP-1 weight-loss medications are designed to be a lifelong treatment. But a new study finds the majority of people who use these drugs quit after just two years
BMI Sidelined in New Obesity Definition That Favors Health Evaluation
Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes an approach that looks at how excess body fat affects health
Read all the stories you want.
The FDA Is Changing What Foods Can Be Called ‘Healthy’
Whole grains and fruits are in, and added sugar is out. That’s going to change what’s on a lot of cereal boxes and other things
Teenagers Are Taking New Weight-Loss Drugs, but the Science Is Far from Settled
Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known about their long-term effects
Obesity-Drug Pioneers Win Prestigious Lasker Award for Medical Science
Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?
Eating Disorders Can Strike Anyone
Misconceptions that eating disorders mostly afflict white, affluent, young females have led to disparities in the treatment of these deadly diseases
People Who Are Fat and Healthy May Hold Keys to Understanding Obesity
“Heavy and healthy” can be a rare or common condition. But either way it may signal that some excess weight is just fine
Cheaper Versions of Popular New Weight-Loss Drugs Are Being Developed
As the patents on various weight-loss drugs near expiration, companies in India and China are vying to make lower-cost versions that will widen access to such treatments
What Happens When You Quit Ozempic or Wegovy?
Many researchers think that Wegovy and Ozempic should be taken for life, but myriad factors can force people off the drugs
First Weight-Loss Drug Gets Approval for Heart Disease. Here’s What We Know
The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some people, but questions remain about how it works
Tubby Labradors May Be at the Mercy of Their Genes, Not Just Too Many Treats
One in four Labrador retrievers carries a gene that tricks their brain into thinking they’re starving
Ozempic and Mounjaro Aren’t the Same. Here’s How Weight-Loss Drugs Compare
A plethora of new weight-loss drugs are now available in the U.S., but they aren’t necessarily the same. Here’s a guide to the latest GLP-1 receptor agonists